AMANDA JENNINGS: Open Payments
NPI 1255981064 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 56 payments from 28 companies in 2025. Trend: 2023 $504 · 2024 $329 · 2025 $1,368
Food & beverage: $1,175Education: $193
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $259 |
| Daiichi Sankyo Inc. | 3 | $128 |
| Incyte Corporation | 2 | $116 |
| Janssen Biotech, Inc. | 5 | $106 |
| Merck Sharp & Dohme LLC | 3 | $86 |
| PFIZER INC. | 4 | $75 |
| ABBVIE INC. | 2 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Exelixis Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: KISQALI, Enhertu, KEYTRUDA, VENCLEXTA, PLUVICTO, CABOMETYX, RYBREVANT, TALVEY.
Industry payments across MO — which companies pay providers there.
